Corbus Pharmaceuticals Holdings, Inc. 4
4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Jan 11, 2016
Insider Transaction Report
Form 4
Tepper Mark
President and CSO
Transactions
- Award
Stock Option(right to buy)
2016-01-07+240,000→ 240,000 totalExercise: $1.40Exp: 2026-01-07→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 7, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 7, 2017.